Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Industry News U.S. Expands Botulism Antitoxin Stockpile With $64.5 Million Contract AwardGlobal Biodefense StaffMay 28, 2026
Medical Countermeasures Saudi Arabia Clears Smallpox and Mpox Vaccine in Signal of Broadening Biodefense PreparednessGlobal Biodefense StaffMay 18, 2026
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College Industry News April 10, 2020 …
DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers Industry News April 9, 2020 …
HHS Announces Ventilator Contract with Philips under Defense Production Act Industry News April 8, 2020 …
Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche Industry News April 8, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Profusa and Partners Announce DARPA-Backed Study to Measure Early Signs of Influenza Biodetection March 11, 2020 …
Coronavirus Surveillance: The Team Behind the Unique Coding System for Disease Tracking Biosurveillance February 7, 2020 …
Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics Industry News January 30, 2020 …
Inflammatix Wins BARDA Backing for Diagnostic to Rapidly Distinguish Bacterial from Viral Infections Antimicrobial Resistance November 25, 2019 …
Rutgers University Receives 2019 Edison Patent Award for Rapid Test for Drug Resistant Tuberculosis Biodetection November 21, 2019 …
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria Antimicrobial Resistance November 11, 2019 …
Diagnosing Sepsis in Minutes: Cytovale Raises $15 Million in Financing Biodetection November 9, 2019 …
Debiopharm Progresses in Their Stand Against Drug-Resistant N. gonorrhoeae Antimicrobial Resistance November 8, 2019 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
